MedTrace Logo

A Study of ARRY-371797 in Subjects Undergoing Third Molar Extraction

NCT00542035 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 103

Last updated 2021-02-21

No results posted yet for this study

Summary

This is a Phase 2 study designed to test the ability of investigational study drug ARRY-371797 to reduce pain either perioperatively or postoperatively in a third molar extraction pain model, and to further evaluate the drug's safety. Approximately 150 subjects from the US will be enrolled in this study.

Conditions

  • Dental Pain

Interventions

DRUG

ARRY-371797, p38 inhibitor; oral

dose 1, dose 2

DRUG

Placebo; oral

dose 1, dose 2

DRUG

Placebo; oral

dose 1

DRUG

ARRY-371797, p38 inhibitor; oral

dose 2

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-11-11
Primary Completion
2008-02-11
Completion
2008-02-11

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00542035 on ClinicalTrials.gov